Pular para o conteúdo principal
Ranking Invest

ETON - Eton Pharmaceuticals, Inc.

Segmento: HealthcareEton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.

Análise Ranking Invest

Valuation estimado
$ 18.83 Mi
Valor de Mercado
$ 1.81 Bi
Sobrepreço (AV)+9527.4%
IVR
0.01A companhia vale 0,01 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
MLL
-0.01A companhia gerou lucro líquido equivalente a -1% do seu valor de mercado nos últimos 4 trimestres.
Último Balanço Atualizado: 1T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 30.61 Mi

Dívida Líquida

$ 11.09 Mi

L4T

-$ 1.48 Mi

MM4T

-2.22%

Indicadores Básicos

ROE

-4.82%

Índices de Previsibilidade

Faturamento

F0.32

Lucro

F2.58

Margem

F4.09

Índices de Tendência

Faturamento

B10.55

Lucro

C1.69

Margem

B4.68

Índices de Endividamento

DIV/PAT

0.36

DIV/L4T

-7.52

Dívidas
Cotação
Gráfico Lucro/Faturamento X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.